GBA1 and Parkinson disease: Since their identification [23,143,144], heterozygous mutations in the gene encoding β-glucocerebrosidase (GCase), GBA1 (GBA), are considered the greatest genetic risk factor for developing PD [9,145] and it is estimated that between 5%–25% of all PD patients carry GBA mutations [146].